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The purpose of this study was to understand the pros and cons of the lengthening nails which have their own mechanical
mechanism; we propose a classification for “device-related complications” arising from mechanical properties of the nail itself.
From March 2010 to March 2014, 115 segments of lower limb lengthening were performed using intramedullary lengthening nails
(35 ISKD, 34 PRECICE1, and 46 PRECICE2). Device-related complications were sorted into three categories according to a new
classification: distraction control-related (type I), stability related (type II), and other device-related (type III); thesewere subdivided
using Paley’s concept of problems (a), obstacles (b), and sequel (c). Most common complications were distraction mechanism
issues (type I) in ISKD and mechanical strength related ones (type II) in PRECICE1 and PRECICE2. Sixty percent (21/35) of
ISKD had device-related problems. In PRECICE1 group, 8.8% (3/34) had device-related problems, and 8.8% (3/34) showed device-
related obstacle. In PRECICE2, forty-four percent (20/46) had device-related problems. In conclusion, a new classification showed
more clearly the differences of mechanical characteristics of different nails. The most essential thing of future lengthening nail
development is minimizing the types I and II complications. Further study is necessary to compare the mechanical strength and
stability of lengthening nails.
1. Introduction
Although external fixators are still the gold standard in the
limb lengthening field, surgical techniques such as length-
ening over nail or lengthening and then nail have been
developed to reduce the period of external fixation [1, 2].
The following four devices are the most clinically known:
the Fitbone (WittensteinIntens, Igersheim, Germany), the
Albizzia (DePuy, Villeurbanne, France), the Intramedullary
Skeletal Kinetic Distractor (ISKD; Orthofix Inc., Lewisville,
Texas, USA), and the PRECICE (Nuvasive, San Diego, CA,
USA). Each of the lengthening nails has its own characteristic
mechanical mechanisms, which could also bring distinct
complications.
The Albizzia is a fully implantable nail that is activated
by torsion of 20∘ along the longitudinal axis of the limb [3–
5]. The Fitbone—an electronic motorized lengthening nail
which does not need rotationalmotion to be lengthened—has
been reported to have 3–17% of device-related reoperation
rate [6, 7].These two devicesmostly have been used in Europe
and known to be upgraded after those reports. The ISKD is
the first FDA-approved intramedullary lengthening nail. It is
activated by the clutch mechanism and expected to provide
comfortable lengthening. Various problems with rate control,
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such as runaway, difficult to distract nail, and nondistracting
nail, have been reported [8–12]; this has further led to
secondary issues such as delayed union/nonunion [8, 12]
and severe pain [9], and was finally discontinued from the
market. Accordingly, success with limb lengthening using
intramedullary lengthening nails highly depends on precise
rate control of distraction, pain resulting from themechanism
of lengthening, and mechanical stability of the device—all of
which are caused directly by the device.
Recently, magnetically actuated telescopic nail, the PRE-
CICE, the second FDA-approved device, is being widely
used around the world [13–16]. Presumed strengths of the
PRECICE are precise control of the distraction and the
reduced pain during lengthening.
To fully understand the pros and cons of each device,
analyses should divide complications resulting from the
device itself from those that are not related to the device.
In this study, authors propose a new classification specially
for the complications that are from the device itself (device-
related complications) and compare outcomes for the two
FDA-approved nails, ISKD and PRECICE; device-related
complications, non-device-related complications, and the
change of alignment and length were compared.
2. Materials and Methods
2.1. Study Design and Subjects. This study includes ISKD,
PRECICE, and PRECICE2. We distinguished PRECICE1 and
PRECICE2; PRECICE2 is a revised one of initial version of
PRECICE. Henceforward, PRECICE2 has been revised to
PRECICE2.1, PRECICE2.2, and currently PRECICE2.3. From
March 2010 to March 2012, we used ISKD, the only available
lengthening nail in our country, and stopped using ISKD in
March 2012 due to rate control issue [9], and switched to
PRECICE nail in May 2013 when it was available since then.
During this period, 115 segments of bones, 88 femurs in 46
patients, and/or 27 tibias in 14 patients underwent length-
ening using one of three intramedullary lengthening nails
(35 ISKD, 34 PRECICE1, and 46 PRECICE2). All patients
underwent lower limb lengthening for stature lengthening
or limb length discrepancy. Detailed patient’s demographics
were tabulated (Table 1). Stature lengthening was the most
common etiology because the lengthening nails have not
been covered by national health insurance, so we have
limitations in using those for disease or posttraumatic cases.
This study was approved by the institutional review board at
our institution. No patient was lost during follow-up.
2.2. Description of Study. The ratio of femur lengthening
to tibia lengthening was 26 : 9 in the ISKDs, 28 : 6 in the
PRECICE1, and 34 : 12 in the PRECICE2, with no significant
difference. Other demographic data including age, sex ratio,
body mass index, smoking history, and final length gain
showed no differences between groups, except the follow-up
period (Table 1).
All surgical procedures were performed by the senior
author (DHL) and were similar to the one described in our
previous report [9]. Weight-bearing was limited to 20 kg
Table 1: Descriptive statistics for the patients along nailing machine
groups.
Demographic variables ISKD(𝑁 = 35)
PRECICE1
𝑁 = 34
PRECICE2
𝑁 = 46
Number of patients 19 18 23
Age (years) 28 ± 8 29 ± 7 29 ± 6
Sex (male : female) 20 : 5 15 : 3 17 : 6
Preoperative height (cm) 154 ± 6 161 ± 7 159 ± 6
Body mass index (kg/cm2) 22 ± 3 23 ± 3 22 ± 4
Smoking history (yes : no) 9 : 26 5 : 29 7 : 33
Final length gain (mm) 48 ± 8 49 ± 8 51 ± 7
Bones lengthened
(femur : tibia) 26 : 9 28 : 6 34 : 12
Duration of follow-up
(months) 48 ± 6 18 ± 4 15 ± 5
Note. Values are expressed as mean ± standard deviation or as a ratio.
Figure 1: Relatively weak distraction force compared to the thick
callus led to the cessation of lengthening. Another osteotomy and
further lengthening were done to accomplish the targeted length.
or less regardless the devices; patients were asked to avoid
weight-bearing as much as possible during lengthening. At
each follow-up visit, radiologic evaluation using the Picture
Archiving and Communication System (PACS, GE Health-
care, Barrington, USA) and clinical evaluation including
range of motion of the adjacent joint were done by senior
author (DHL).
2.3. Variables and Outcome Measures. For comparison of
device-related complications, they were sorted into three cat-
egories: distraction mechanism-related (type I), mechanical
strength related (type II), and other device-related (type III).
Types I and II are related to the primary function of the
nail. Type I is related to the lengthening mechanism and
provides the most direct influence on reaching the target
length. This includes runaway [9], difficult to distract nail
[9], nondistracting nail [9], nonfunctioning nail, and running
back [9] (Figure 1). Type II is primarily related to themechan-
ical strength (stability) of the nail. This can cause instability
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Figure 2: (a)The immediate postoperative plain radiograph showed straight tibia PRECICEnail. (b)The tibia PRECICEnail was bent without
breakage after 2 months of lengthening. This was categorized as stability related problem (IIa).
of the bone, secondary deformity, or prolonged limitation
of weight-bearing. Type II complication may include nail
bending (Figure 2), nail breakage, or rotational instability.
Bending of the nail was defined as over two degrees of the
difference between the axis of proximal part and distal part of
the nail. Type III is separate from previous two complications
and, in principle, does not affect the primary functions of the
nail, such as corrosion or adverse reaction of the tissues. Each
category was subdivided using Paley’s concept of problem
(a), obstacle (b), and sequela (c) (in this paper, we changed
the term “complication” of Paley’s original classification into
“sequela” to avoid confusion in terminology) [1, 17] (Table 2).
Non-device-related complications were also collected
including joint contracture, deep vein thrombosis, or deep
infections. Some complications such as delayed union,
nonunion, or temporary hypoesthesia were difficult to clearly
classify into device-related complications or non-device-
related complications.The rate control (Type I device-related
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Table 2: Device-related complications for internal lengthening devices.
Device-related complications Description
(I) Distraction control-related
Problem like this can primarily prevent the lengthening target from being met or causes regenerate
problems
Runaway, difficult to distract nail, running back, nondistracting nail
(a) Problem/(b) obstacle/(c) sequela
(II) Stability related
Problem like this will primarily cause secondary deformity, instability of the bone or limited weight
bearing
Nail bending/breakage, rotational instability
(a) Problem/(b) obstacle/(c) sequela
(III) Other device-related
Device problems that in principle do not affect the primary functions of the device
Corrosion, adverse reaction of tissue
(a) Problem/(b) obstacle/(c) sequela
complications) could be thought to affect the incidence of
those complications, but we still cannot exclude the possible
other host-related factors or surgical technique-related issues
as a cause. So, we classified these complications into “non-
device-related complications” uniformly in the current study.
The change of alignment and length was evaluated by
following measurements; the change of femorotibial angle
was checked with orthoradiograph between preoperative and
the last follow-up; the change in sagittal plane (femoral
bowing in the femur and posterior proximal tibial angle in
the tibia) was checked with standing lower extremity-lateral
radiograph between preoperative and the last follow-up. The
differences between planned and actual length were also
checked using orthoradiograph at the last follow-up.
2.4. Statistics. The statistical software, R (ver. 2.12 Compre-
hensive R Archive Network, GNU General Public License,
Wien, Austria), was used for all statistical analysis. All con-
tinuous variables were tested for normality using the Shapiro-
Wilk test and followed a normal distribution. Each contin-
uous measurement is expressed as mean ± SD with range.
Chi-squared test of the independence was used for analysis of
device-related complication. Because of small sample sizes of
non-device-related complications, statistical test could not be
conducted for the non-device-related complicationwith both
parametric and nonparametric method. Three of the authors
who were orthopedic surgeons measured all radiographic
parameters and findings. All of them were blinded to subject
information while measuring. We evaluated the intraob-
server reliability by repeating all radiologic assessments after
1 week. The intraclass correlation coefficients (ICC) value of
the intraobserver reliability was 0.968, and ICC value of the
interobserver reliability was 0.913. 𝑃 value of less than 0.05
was considered statistically significant.
3. Results
Device-related complications are summarized in Table 3.
Overall rate of device-related complication showed 74.3%
(26/35), 17.6% (6/34), and 50% (23/46) in ISKD, PRECICE1,
and PRECICE2 groups, respectively, which is significantly
different.
3.1. Type I (DistractionControl-RelatedComplications). In the
ISKD group, 22 cases (63%) had rate control problems, and
four cases (12%) had additional surgery (Ib). In the PRE-
CICE1 group, failure of lengthening during distraction phase
due to dense regenerate occurred in two cases (5.9%, Ib)
(Figure 1). In the PRECICE2 group, running back occurred
in one case (2.2%) which completed lengthening without
additional surgery (Ia) and mechanical dysfunction which
needed additional surgery (Ib) in one case (2.2%). No cases
demonstrated sequelae at the end of the treatment.
3.2. Type II (Stability Related Complications). There were two
cases of nail bending without a breakage in the ISKD group.
The PRECICE1 group had three bent nails without breakage
(IIa) and one nail breakage (2.9%, IIb). In the PRECICE2
group, 7 segments (15.2%) had nail bending without breakage
(IIa) (Figure 2). All of this occurred in smallest diameter
nail (8.5mm) which in only available in PRECICE2 and this
occupies 35% of 8.5 diameter nail used (7/20) (Table 3).
Twelve segments of PRECICE2 (26.1%) showed breakage of
rotation coupling without instability (IIa) (Figure 3). All of
this occurred in femoral lengthening regardless diameter
of the nail. Two segments of PRECICE2 (4.3%; failure of
rotational stability) had additional surgery (IIb) (Figure 4).
3.3. Type III (Other Device-Related Complications). No prob-
lems were observed for this type of complication.
3.4. Device-Related “Problem” (Types Ia, IIa, and IIIa). Over-
all rate of device-related problem showed 60% (21/35), 8.8%
(3/34), and 43.5% (20/46) in ISKD, PRECICE1, and PRE-
CICE2 group, respectively. Type I occupied 85.7% (18/21)
of the problems in ISKD group and type 2 occupied 100%
(3/3) and 95% (19/20) in PRECICE 1 and PRECICE2 group,
respectively.
3.5. Device-Related “Obstacle” (Types Ib, IIb, and IIIb). Over-
all rate of device-related obstacle showed 14.3% (5/35), 8.8%
(3/34), and 6.5% (3/46) in ISKD, PRECICE1, and PRECICE2
groups, respectively. Type I occupied 80% (4/5) and 66.7%
(2/3) of the problems in ISKD and PRECICE 1 groups,
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Table 3: Device-related complication.
Complication ISKD
𝑁 = 35
PRECICE1
𝑁 = 34
PRECICE2
𝑁 = 46
Ia
18 (51%) 1 (2.2%)
Runaway nail: 6
Difficult to distract nail: 12 Running back
Ib
4 (12%) 2 (5.9%) 1 (2.2%)
Nondistracting nail: 3
Failure of lengthening mechanism:
1
Dense regenerated callus Nonfunctioning nail
Ic
Total type I 22 (63%) 2 (5.9%) 2 (5.9%)
IIa
3 (8.6%) 3 (8.8%) 19 (41%)
Nail bending without breakage: 2 Nail bending without breakage Nail bending without breakage: 7
Breakage of rotation coupling
without instability: 1
Breakage of rotation coupling
without instability: 12
IIb 1 (2.9%) 2 (4.3%)
Nail breakage Rotational stability
IIc
Total type II 3 (8.6%) 4 (11.8%) 21 (46%)
III
Note. Actually, Type III (other device-related complications) complication was not observed.
(a) (b) (c)
Figure 3: (a) “Rotation coupling” which is at the junction between telescoping rod (arrow head) is intact before lengthening. (b)
Disconnection of rotation coupling is seen in PRECICE2 (arrow). Since it was not associated with instability, this was categorized as stability
related problem (IIa). (c) Damaged rotation coupling is noticed in the retrieved PRECICE2 nail.
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Figure 4: (a) A 38-year-old woman who underwent bilateral femur lengthening complained that she abruptly cannot be able to control her
left leg, just after “popping sense” on the leg during early consolidation phase. To confirm the failure of rotational stability of the nail, the
CT scans of lower extremity with maximal internal and maximal external rotation were taken, respectively.The femoral rotational alignment
changed to about 20 degrees according to the patient’s position. (b) Additional mono-fixator was applied to gain a proper rotational alignment
and stability until the consolidation is finished.
Table 4: Non-implant-related complications.
Complications encountered ISKD group
𝑁 = 35
PRECICE1
𝑁 = 34
PRECICE2
𝑁 = 46
𝑃 value
Non-device-related problems
Transient hypoesthesia 3 (9%) 1 (2.9%) 1 (2.2%) 0.335
Heterotrophic ossification 3 (9%) 1 (2.9%) 0 (0%) 0.111
Delayed union 4 (11%) 0 (0%) 2 (2.2%) 0.097
Non-device-related obstacles 2 (6%) 0 (0%) 2 (2.2%) 0.397
Non-device-related complications 0 (0%) 0 (0%) 0 (0%)
respectively. Type 2 occupied 66.7% (2/3) in PRECICE2
group.
3.6. Device-Related “Sequela” (Types Ic, IIc, and IIIc). No
cases demonstrated sequelae at the end of the treatment.
3.7. Non-Device-Related Complications. In the ISKD group,
non-device-related problems, such as transient hypoesthesia,
heterotopic ossification, and delayed union, occurred rela-
tively more than the other groups. There were two segments
of surgical release due to hip contracture in both ISKD and
PRECICE2. There were no cases in all groups with deep
infection or nonunion (Table 4).
3.8. The Change of Alignment and Length. Acute corrections
of the alignment during surgery were done in 8 segments of
the tibia to correct 5∘ to 12∘ of varus. There was a tendency of
valgus deviation in tibial lengthening in all groups. In sagittal
plane, the changes were not significant. The differences
between planned and actual length were within 3mm in all
cases (Table 5).
4. Discussion
Since the 1970s, several intramedullary lengthening nails have
been developed to avoid various complications caused by
long periods of external fixation [5, 6, 16, 18]. However,
many of these have showed some issues associated with the
lengtheningmechanism or strength of the nail which resulted
in nonoptimal results [5, 7–10, 12, 19, 20].
Many issues that occur during lengthening, such as pain,
mechanical failure, and imprecise rate control, can be due
mostly to the device itself not under control of the surgeon.
This differs from external fixation procedures, and it is often
difficult to resolve such issues with nonsurgical techniques.
Therefore, it is necessary to categorize complications into
device-related complications and non-device-related compli-
cations.
Thus far, only ISKD and PRECICE have received FDA
approval, and each is activated by different mechanisms. In
comparing the device-related complications of these nails,
this study design has the advantages of being a single-center,
single-surgeon series, having no demographic differences
among the cohorts. We found that the lowest rate of overall
device-related complication was seen in PRECICE1 (17.6%),
lowest device-related problem in PRECICE1 (8.8%), and low-
est device-related obstacle in PRECICE2 (6.5%). PRECICE
nails showed less distraction control-related complications
(type I) and less pain, but more mechanical strength related
complications (type II) than ISKD.
Several limitations should be mentioned. First, PRE-
CICE2 has been revised up to version 2.3 which tried to
upgrade the mechanical strength and stability. The next ver-
sions of the product family after PRECICE2 are not included
in this study. And themodel ISKD is out of production due to
its unpredictable rate control. So, the current study does not
provide the information of product of the lengthening nails
which are available in the market. But authors performed
this study to suggest the classification of the device-related
complications of lengthening nails. Second, we had a small
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Table 5: The change of alignment and length among different lengthening nails.
ISKD
𝑁 = 35
PRECICE1
𝑁 = 34
PRECICE2
𝑁 = 46
Femur Tibia Femur Tibia Femur Tibia
The change of femorotibial
angle (∘)∗ −0.3 (−3 to 3.2) −1.7 (−3 to 3.2) −1.1 (−4 to 0.7) −5.1 (−8.8 to −3.2) 0 (−3.8 to 3.2) −2.8 (2.1 to −6.7)
The change of sagittal
alignment (∘)∗∗ −0.3 (−2 to 1) 0.4 (0 to 1) −0.5 (−2 to 1) 0 (0 to 0.5) 0 (−2 to 4) 0 (0 to 0.5)
The differences between
planned and actual length
(mm)
−2 (−4 to 3) 2 (−3 to 3) −1 (−3 to 2) 1 (−2 to 3) 0 (−2 to 3) −2 (−2 to 3)
∗
+means varus and −means valgus alignment; ∗∗+means flexion and −means extension alignment.
number of tibia lengthening patients in both groups, which
limited our ability to subcategorize or analyze them. A study
with a larger sample for tibial lengthening is necessary.Third,
this is a consecutive series, with the ISKD being done first,
followed by the PRECICE. We cannot exclude the fact that
the PRECICE patients did better because the senior author
became more experienced with lengthening nails.
The general classifications of complications in limb
lengthening were proposed by Caton et al. in 1985 [21], Paley
in 1990 [17], Popkov in 1991 [22], Donnan et al. in 2003 [23],
and Lascombes et al. in 2012 [24]. Lascombes et al. especially
classified the complications in more universal manner after
different interventions and differing osteosynthesis methods
[24]. However, these classifications are for the general com-
plications of distraction osteogenesis, not specific for the
internal bone lengthening devices. Unlike external fixator,
lengthening nails have complex mechanical mechanism and
this may lead to characteristic complications. Therefore, we
believe, apart from the conventional classification system for
the general complications of distraction osteogenesis, a new
classification for the complications caused by the mechanical
problems of the lengthening nail will help in analyzing the
character of each nail.
Difficulties of rate control have been reported to be a
major disadvantage of ISKD [5, 7, 9, 25]. Predictable control
of the distraction rate is critical for callus regeneration,
soft tissue adaptation, and pain in distraction osteogenesis.
Uncontrolled rate can result in nonunion or premature
consolidation, soft tissue damage, and severe pain [5, 7, 9].
Lee et al. observed an abnormal distraction rate of 60% in
an ISKD study [9], and many studies have reported poor
regeneration linked to ISKD distraction rates that are too
high (runaway) [8, 10, 12]. The overall rate of device-related
problems (Ia, IIa) was 60% for ISKD, 8.8% for PRECICE1,
and 43.5% for PRECICE2. The most common device-related
problem of ISKD was type I (distraction control-related),
and even though they were managed without an additional
surgery, those cases with runaway or difficult to distract
nail were hard to manage properly. In PRECICE2, most of
device-related problems were nail bending or breakage of
rotation coupling without actual instability (type II). Nail
bending in PRECICE2 was observed in smallest diameter
nail (8.5mm) which in only available in PRECICE2 and
this occupies 35% of 8.5 diameter nail used (7/20). Small
diameter nails are necessary for the patients with narrow
intramedullary canal, especially in East Asia. However, it
seems to be necessary to have a strongermechanical character
in order to avoid the bending phenomenon, since “bending”
may change the alignment and be exposed to the risk of
nail breakage. Twelve cases using PRECICE2 (26.1%) showed
breakage of rotation coupling without instability (IIa). All
of this occurred in femoral lengthening regardless diameter
of the nail. This shows the importance of higher stability
against the rotational force regarding the femoral lengthening
nail. The additional surgeries were caused mainly by a
nonfunctioning nail and painfully distracting nail (difficult
to distract nail) for ISKD (4–33%) [9–11, 19], whereas the
main causes were nonfunctioning nail and nail fracture for
PRECICE1 (0–19%) [14, 15, 25, 26]. In contrast to the most
common device-related obstacle was type I (nondistracting
nail or failure of lengthening mechanism) in ISKD; weak
distraction force to resist a dense regenerate or nail breakage
at the modular portion is the cause of additional surgery in
PRECICE1. This has been reported in the previous studies
[13, 26] and PRECICE2 is known to be developed to improve
these weaknesses. In this study, PRECICE2 showed no more
fracture of the nail or weak distraction force. But we observed
a new weakness in PRECICE2, failure of rotational stability
which resulted in additional surgery.
Pain caused by the lengthening mechanism is especially
reported with the use of lengthening nails that require rotat-
ing motion; Guichet and Casar reported an average of one
additional operation on each limb due to ratcheting under
general anesthesia using Albizzia nails [4]. Garcı´a-Cimbrelo
et al. reported 2/24 cases (8%) of ratcheting under general
anesthesia for femoral lengthening using Albizzia nails and
further reported that, in 3/24 cases (13%), the patients wanted
early termination of lengthening due to severe pain during
ratcheting [27]. An average VAS for pain of 7-8 has been
reported for ISKD lengthening [7], but this study involving
the same design reports a lower VAS in PRECICE groups for
pain of 3-4 during lengthening motion. We believe that this
is due to lack of rotational movement for lengthening and
accurate distraction rate control of the PRECICE nail.
Non-implant-related additional surgeries (obstacles)
were all caused by hip contracture from femoral lengthening
and were successfully released by additional surgery. Delayed
unions, all seen in tibial lengthening, weremore seen in ISKD
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group than PRECICE group. Statistical analysis regarding
tibial lengthening is not possible due to small number of
cases; however, the authors are suggesting that rotational
movement gives a bad influence on healing of the tibia which
has relatively lower healing potential. A very low rate of
non-implant-related complications, especially deep infection
and nonunion, in all devices shows promising potential of
intramedullary lengthening nails, but we believe this can be
achieved only when it is well controlled by an experienced
surgeon.
In conclusion, analysis of device-related complications
by a new classification showed the differences of mechanical
characteristics of different lengthening nails more clearly.
The most essential thing in lengthening nails which are
to be developed in the future is minimizing the types I
and II complications. Further study is necessary to compare
the mechanical strength and stability of the upmost revised
versions of lengthening nails which are available in the
market.
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